Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-12-01T02:35:28.074Z Has data issue: false hasContentIssue false
  • English
  • Français

Suppression of Gastrin Production after Cisplatin Treatment in Rats

Published online by Cambridge University Press:  02 July 2020

Y. Wang  and
S. K. Aggarwal
Y. Wang
Affiliation:
Department of Zoology, Michigan State University, East Lansing, MI48824
S. K. Aggarwal
Affiliation:
Department of Zoology, Michigan State University, East Lansing, MI48824
Get access

Extract

Cisplatin, a commonly used broad spectrum chemotherapeutic drug, has been proven effective in the treatments of bladder, lung, ovarian, head and neck, testicular and breast cancers. One of the major side effects of this drug is its gastrointestinal toxicity, which includes severe nausea, vomiting and in case of rats bloating of the stomach and gastric ulceration. In case of rats, it manifests as bloating of the stomach and gastric ulceration since the rats don't have vomiting reflex. This has been attributed to hypocalcemia induced by cisplatin treatment which results in the suppression of acetylcholine and constitutive nitric oxide release inducing a bloating of the stomach. This has further been shown to induce an increase in the acid content of the stomach. There are no studies available on any changes of gastric protection after cisplatin treatment Gastrin has been shown to have gastroprotective effects against injury by maintaining the gastric mucosal integrity and gastric mucosal blood flow.

Type
Cytochemistry (Light and Electron Histochemistry)
Information
Microscopy and Microanalysis , Volume 4 , Issue S2: Proceedings: Microscopy & Microanalysis '98, Microscopy Society of America 56th Annual Meeting, Microbeam Analysis Society 32nd Annual Meeting, Atlanta, Georgia July 12-16, 1998 , July 1998 , pp. 1120 - 1121
Copyright
Copyright © Microscopy Society of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References:

1.Aggarwal, S. K. et al., Anticancer Drugs. 5(1994): 177CrossRefGoogle Scholar
2.Jarve, R. and Aggarwal, S. K.. Cancer. Chemother. Pharmarcol. 39(1997): 341CrossRefGoogle Scholar
3.Konturek, S. J. et al., Eur J Pharmacol 278(1995): 203CrossRefGoogle Scholar
4.Hsu, S. et al., J Histochem Cytochem 29(1981): 577CrossRefGoogle Scholar
5.Larsson, L. I. etal., J Histochem Cytochem 41(1993): 157CrossRefGoogle Scholar